c11111110sc13g.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b),
(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2
 
(Amendment No. __)
 
Trinity Biotech plc

(Name of Issuer)
 
American Depository Shares (each representing 4 ‘A’ Ordinary Shares, par value US$0.0109)

(Title of Class of Securities)
 
896438306

(CUSIP Number)
 
November 4, 2011

(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
o
Rule 13d-1(b)
   
x
Rule 13d-1(c)
   
o
Rule 13d-1(d)

 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


 
 

 
 
CUSIP NO. 896438306
13G
Page 2 of 9
 
 
1
NAMES OF REPORTING PERSONS
 
Park West Asset Management LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) 
(a) o
(b)  o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
 
SHARES
 
BENEFICIALLY
 
OWNED BY
 
EACH
 
REPORTING
 
PERSON
 
WITH:
5
SOLE VOTING POWER
 
1,058,576
6
SHARED VOTING POWER
 
-0-
7
SOLE DISPOSITIVE POWER
 
1,058,576
8
SHARED DISPOSITIVE POWER
 
-0-
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,058,576
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 
o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (19)
 
5.1%
12
TYPE OF REPORTING PERSON (See Instructions)
 
CO

 
2 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 3 of 9
 
 
1
NAMES OF REPORTING PERSONS
 
Peter S. Park
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) 
(a) o
(b)  o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States of America
NUMBER OF
 
SHARES
 
BENEFICIALLY
 
OWNED BY
 
EACH
 
REPORTING
 
PERSON
 
WITH:
5
SOLE VOTING POWER
 
1,058,576
6
SHARED VOTING POWER
 
-0-
7
SOLE DISPOSITIVE POWER
 
1,058,576
8
SHARED DISPOSITIVE POWER
 
-0-
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,058,576
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 
 
 
o
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (19)
 
5.1%
12
TYPE OF REPORTING PERSON (See Instructions)
 
IN

 
3 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 4 of 9
 
 
Item 1.
     
 
(a)
Name of Issuer:
Trinity Biotech plc (the “Company”)
     
 
(b)
Address of Issuer’s Principal Executive Offices:
IDA Business Park
Bray, Co. Wicklow
Ireland

Item 2.
     
 
(a)
Name of Persons Filing:
(1) Park West Asset Management LLC, a Delaware limited liability company (“PWAM”) and
(2) Peter S. Park (collectively, the “Reporting Persons”)
     
 
(b)
Address of Principal Business Office or, if none, Residence:
900 Larkspur Landing Circle, Suite 165, Larkspur, California 94939
     
 
(c)
Citizenship:
(1) Delaware
(2) United States of America
     
 
(d)
Title of Class of Securities:
American Depository Shares (each representing 4 ‘A’ Ordinary Shares, par value US$0.0109) (the “Issuer ADSs” or “Shares”)
     
 
(e)
CUSIP Number:
896438306

Item 3.
   
 
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
 
(a)
o
Broker or dealer registered under section 15 of the Act.
       
 
(b)
o
Bank as defined in section 3(a)(6) of the Act.
       
 
(c)
o
Insurance company as defined in section 3(a)(19) of the Act.
       
 
(d)
o
Investment company registered under section 8 of the Investment Company Act of 1940.
       
 
(e)
o
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
 
(f)
o
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
 
 
4 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 5 of 9
 

 
(g)
o
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
 
(h)
o
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act;
       
 
(i)
o
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       
 
(j)
o
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

Item 4.
   
 
Ownership
   
 
(a)
Amount beneficially owned:
 
PWAM is the investment manager of Park West Investors Master Fund, Limited, a Cayman Islands exempted company (“PWIMF”), and Park West Partners International, Limited, a Cayman Islands exempted company (“PWPI”).  Peter S. Park is the sole member and manager of PWAM.
 
As of November 4, 2011, the Reporting Persons’ beneficial ownership were as follows:  (i) PWAM indirectly beneficially owned 1,058,576 Shares, consisting of 864,361 Shares held by PWIMF and 194,215 Shares held by PWPI; and (ii) Peter S. Park, as sole member and manager of PWAM, indirectly beneficially owned the 1,058,576 Shares indirectly beneficially owned by PWAM.
 
The Reporting Persons have, within the ordinary course of business, purchased securities of the Company.  The Reporting Persons have not acquired securities in the Company with the purpose, nor with the effect of changing or influencing the control of the issuer, nor in connection with or as a participant in any transaction having such purpose or effect.  The Reporting Persons have purchased, and may in the future purchase, shares on the open market at prevailing prices.
     
     
 
(b)
Percent of class :
 
As of November 4, 2011, the Reporting Persons’ beneficial ownership, were as follows:  (i) PWAM indirectly beneficially owned 5.1% of the outstanding Issuer ADSs and (ii) Peter S. Park indirectly beneficially owned 5.1% of the outstanding Issuer ADSs (based on 20,807,943 Shares outstanding).
     
 
(c)
Number of shares as to which the person has:
     
   
(i)
Sole power to vote or to direct voting — PWAM and Peter S. Park, as its sole member and manager, each have the sole power to vote or to direct the vote of 1,058,576 Shares.
 
 
5 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 6 of 9
 
 
   
(ii)
Shared power to vote or to direct voting — Neither PWAM, Peter S. Park, as its sole member and manager, have shared power with respect to the voting or direction of voting with respect to the Shares they beneficially own.
       
   
(iii)
Sole power to dispose or to direct disposition — PWAM and Peter S. Park, as its sole member and manager, each have the sole power to dispose or direct the disposition of 1,058,576 Shares.
       
   
(iv)
Shared power to dispose or to direct disposition — Neither PWAM, Peter S. Park, as its sole member and manager, have shared power with respect to the disposition or direction to dispose of the Shares they beneficially own.

Item 5.
   
 
Ownership of Five Percent or Less of a Class
   
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 

Item 6.
   
 
Ownership of More than Five Percent on Behalf of Another Person.
   
Peter S. Park is the sole member and manager of PWAM.
 

Item 7.
   
 
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
   
Not Applicable.
 

Item 8.
   
 
Identification and Classification of Members of the Group
   
Not Applicable.
 

Item 9.
   
 
Notice of Dissolution of Group
   
Not Applicable.
 
 
6 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 7 of 9
 

Item 10.
   
 
Certification
   
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
 
 
7 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 8 of 9
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 

 
 
November 14, 2011
Date
 
 
 
 
PARK WEST ASSET MANAGEMENT LLC
 
       
 
By:
/s/James J. Watson
 
 
Name:
James J. Watson
 
 
Title:
Chief Financial Officer
 
       
       
       
 
/s/Peter S. Park
 
 
Peter S. Park
 
       

 

 
 
 
 
8 of 9 Pages

 
 
CUSIP NO. 896438306
13G
Page 9 of 9
 
 
Exhibit 1
 
 
JOINT FILING AGREEMENT
 
 
In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, no par value, of Trinity Biotech plc; and further agree that this Joint Filing Agreement be included as Exhibit 1.  In evidence thereof, the undersigned hereby execute this agreement this 14th day of November, 2011.
 

 
 
 
November 14, 2011
Date
 
 
 
 
PARK WEST ASSET MANAGEMENT LLC
 
       
 
By:
/s/James J. Watson
 
 
Name:
James J. Watson
 
 
Title:
Chief Financial Officer
 
       
       
       
 
/s/Peter S. Park
 
 
Peter S. Park
 
       


 

 
9 of 9 Pages